ArticleOncotarget2018

Eukaryotic translation initiation factor 3 subunit C is associated with acquired resistance to erlotinib in non-small cell lung cancer.

Takuya Shintani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.